Carbubarb
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 960-05-4 |
| ATC code | ? |
| PubChem | CID 13743 |
| ChemSpider | 13148 |
| UNII | SIW4YR11ST |
| Synonyms | Carbubarb |
| Chemical data | |
| Formula | C11H17N3O5 |
| Mol. mass | 271.270 g/mol |
|
|
|
|
| |
|
Carbubarb (Carbubarbital, Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.[1]
References [edit]
- ^ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto
|
|||||||||||||||||||||||||||||
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |